Does anti-doping violate medical privacy?
Since WADA (1999), athletes must report whereabouts and urinate in view for samples — a surveillance and testing regime the authors say clashes with medical-ethics norms and received privacy.
Source
Current anti-doping policy: a critical appraisal
What they did
They reconstruct the WADA-AMA framework, the whereabouts rule and observed urination, and argue the normative framework plays out as costly surveillance increasingly at odds with medical ethics.
What they found
Such observed collection would be unacceptable in any other setting except perhaps imprisonment, yet is treated as ethical in elite sport. Privacy is the casualty of the testing regime.
The limits
What it doesn't show
This is a 2007 critical appraisal, not a new prevalence study of doping. It does not design an alternative code in detail.
Key terms
- WADA-AMA
- World Anti-Doping Agency / Agence Mondiale Anti-Dopage, source of the post-1999 global code.
- Whereabouts rule
- Athletes must keep authorities informed of day-to-day location for unannounced tests.
- Observed urination
- Sample collection in full view of another person — extreme bodily surveillance.
- Medical-ethics clash
- The claim that this regime conflicts with ordinary medical confidentiality and privacy norms.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
WADA dates from?
Common questions
What must athletes report?
Day-to-day whereabouts so they can be tested.
What is the ethical clash?
Costly surveillance and medical testing vs medical ethics and personal privacy.
Comparator for observed urination?
Unacceptable elsewhere except perhaps imprisonment.
More on Privacy & data